AI assistant
AbbVie Inc. — Director's Dealing 2025
May 13, 2025
29755_dirs_2025-05-13_1a3c5cc3-4d2a-4042-b35d-7b92eb0bb617.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2025-05-09
Reporting Person: FALK THOMAS J (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-09 | Common Stock, $0.01 par value | A | 1203 | — | Acquired | 1203 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.01 par value | 3000 | Indirect |
Footnotes
F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from
service, death, or the occurrence of a change in control (as defined in the Program).
F2: The securities are owned by a limited partnership that is jointly controlled by the reporting person and his spouse. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.